Social Media
The Challenge
Likarda, an emerging biotech company specializing in breakthrough cell therapy technology, sought to amplify its presence on LinkedIn to reach potential partners and investors. The goal was to engage an audience interested in innovative health treatments, clinical trials, and advanced therapeutics. The company needed to boost its follower base, improve engagement rates, and drive meaningful interactions with industry professionals.
The Solution
We began by analyzing Likarda’s existing LinkedIn strategy and identifying key areas for improvement. Our approach included a comprehensive content strategy revamp, focusing on more targeted and engaging posts that highlight Likarda’s technological advancements and industry insights. Implementing refined targeting tactics allowed us to reach professionals in relevant sectors such as diabetes treatments, healthcare innovation, animal health, and drug delivery. Maintaining a regular posting schedule ensured Likarda would remain top of mind and keep followers engaged. Additionally, we executed strategically boosted posts to increase visibility, attract high-quality followers and encourage participation in webinars.
The Result
Since Lundmark’s involvement, Likarda’s LinkedIn metrics have seen significant improvements. This strategic shift to quality content has led to a stronger and more engaged follower base, showcasing the effectiveness of the revamped content strategy. Their overall follower count has increased by over 16%, with most new followers being senior-level decision-makers in biotech and healthcare, a primary audience identified at the start of the partnership. Meanwhile, posts are averaging a 7% engagement rate, more than double the industry standard—a sign that the content Lundmark is developing is relevant and engaging to the growing follower base.
